Skip to main content
Equibles

BARCLAYS PLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 312069 LONDON, X0
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,465,497
+$956,536 QoQ
Shares Held
70,970
+8.5% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. AVBP ranks #62 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,465,497 70,970
2026-03-31 $1,508,961 65,408
2025-12-31 $2,598,960 129,173
2025-09-30 $2,397,300 129,935
2025-06-30 $2,551,704 117,212
2025-03-31 $750,378 40,583
2024-12-31 $1,425,213 53,499
2024-09-30 $975,767 41,522
2024-06-30 $62,884 3,390
2024-03-31 $253,754 14,208